CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang
Otto O
OO
Division of Infectious Diseases/Department of Medicine, UCLA Medical Center, 37-121 Center for Health Sciences, 10833 LeConte Avenue, Los Angeles, CA 90095, USA. oyang@mednet.ucla.edu
D016915:AIDS Vaccines / Q000276:immunology; D000818:Animals; D002454:Cell Differentiation; D018450:Disease Progression; D015195:Drug Design; D006678:HIV / Q000235:genetics / Q000276:immunology; D015488:HIV Antigens / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D008251:Macaca; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014766:Viremia / Q000276:immunology
D016915:AIDS Vaccines; D015488:HIV Antigens